Laurion Capital Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Laurion Capital Management’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,990	Closed	-$46.2K	–	726
2023 Q2	$46.2K	Hold	11,990	–	–	﹤0.01%	567
2023 Q1	$36.2K	Hold	11,990	–	–	﹤0.01%	414
2022 Q4	$24.6K	Hold	11,990	–	–	﹤0.01%	394
2022 Q3	$41K	Hold	11,990	–	–	﹤0.01%	457
2022 Q2	$50K	Hold	11,990	–	–	﹤0.01%	425
2022 Q1	$36K	Sell	11,990 -3,063	-20%	-$11.7K	﹤0.01%	508
2021 Q4	$70K	Hold	15,053	–	–	﹤0.01%	516
2021 Q3	$116K	Sell	15,053 -5,252	-26%	-$40.1K	﹤0.01%	647
2021 Q2	$175K	Sell	20,305 -4,695	-19%	-$41.4K	﹤0.01%	653
2021 Q1	$284K	Buy	+25,000	New	+$392K	﹤0.01%	656

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

Laurion Capital Management's DBTX Position: Q3 2023 in Review

Laurion Capital Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 11,990 shares — an estimated $46.2K sold.

Laurion Capital Management first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $284K in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Laurion Capital Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Laurion Capital Management sold 11,990 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $46.2K.
Laurion Capital Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Laurion Capital Management's Decibel Therapeutics, Inc. Common Stock position peaked at $284K in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.